Vikas R Dharnidharka
Overview
Explore the profile of Vikas R Dharnidharka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
2584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seifert M, Kho A, Sheward L, Rodig N, Goldberg S, Diehl M, et al.
Clin J Am Soc Nephrol
. 2025 Mar;
PMID: 40067364
Background: Recent studies indicate that up to 36% of pediatric and adult kidney transplant recipients with stable serum creatinine levels will have acute rejection detected on surveillance biopsy. The purpose...
2.
Blosser C, Marks L, Dharnidharka V
Am J Transplant
. 2025 Mar;
PMID: 40064296
No abstract available.
3.
Ghezzo A, Pascale G, Dew M, Rennick J, DeVito Dabbs A, Dharnidharka V, et al.
Pediatr Transplant
. 2025 Jan;
29(1):e70006.
PMID: 39776082
Background: The COVID-19 pandemic led to widespread adoption of virtual communication platforms. Virtual study visits were implemented in the pilot cluster randomized trial (CRT) stage of Teen Adherence in KidnEy...
4.
Dandamudi R, Vyas N, Hmiel S, Dharnidharka V
Pediatr Transplant
. 2024 Dec;
29(1):e14883.
PMID: 39725645
Background: Pediatric kidney transplant recipients experience creeping creatinine, which is a slow increase in serum creatinine over time. Distinguishing between normal growth-related changes and possible allograft dysfunction becomes challenging when...
5.
Dharnidharka V, Wylie K, Wylie T, Ruzinova M, Goss C, Storch G, et al.
Transplant Direct
. 2024 Oct;
10(11):e1723.
PMID: 39473523
Post-transplant lymphoproliferative disorders (PTLDs) remain a feared complication of transplantation, with significant morbidity and mortality. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in 50%-80% of cases. Numerous...
6.
Sablik M, Sannier A, Raynaud M, Goutaudier V, Divard G, Astor B, et al.
N Engl J Med
. 2024 Oct;
392(8):763-776.
PMID: 39450752
Background: The heterogeneous clinical presentation of graft microvascular inflammation poses a major challenge to successful kidney transplantation. The effect of microvascular inflammation on allograft outcomes is unclear. Methods: We conducted...
7.
Sagcal-Gironella A, Merritt A, Mizuno T, Dharnidharka V, McDonald J, DeGuzman M, et al.
J Clin Trials
. 2024 Jul;
14(4).
PMID: 39035447
Background: The safety and efficacy of mycophenolate mofetil (MMF) for lupus nephritis (LN) treatment is established in adults and in some children. MMF is rapidly converted to the biologically active...
8.
Dharnidharka V, Scobell R, Kallash M, Davies A, Marchesani N, Maltenfort M, et al.
Pediatr Nephrol
. 2024 Jul;
39(11):3317-3331.
PMID: 39001911
Background: Recurrence of focal segmental glomerulosclerosis (FSGS) or steroid-resistant nephrotic syndrome (SRNS) after kidney transplant leads to significant morbidity and potentially earlier allograft loss. To date however, reported rates, risk...
9.
Soranno D, Amaral S, Ashoor I, Atkinson M, Barletta G, Braun M, et al.
Pediatr Nephrol
. 2024 Jul;
39(12):3609-3619.
PMID: 38976042
Importance: Pediatric patients with complex medical problems benefit from pediatric sub-specialty care; however, a significant proportion of children live greater than 80 mi. away from pediatric sub-specialty care. Objective: To...
10.
Aubert O, Ursule-Dufait C, Brousse R, Gueguen J, Racape M, Raynaud M, et al.
Nat Med
. 2024 Jun;
30(8):2320-2327.
PMID: 38824959
Donor-derived cell-free DNA (dd-cfDNA) is an emerging noninvasive biomarker that has the potential to detect allograft injury. The capacity of dd-cfDNA to detect kidney allograft rejection and its added clinical...